The president doesn’t really pride himself on his ethics, mainly because he has none. There is nothing Donald Trump won’t do to get rid of the coronavirus so we can all concentrate on what matters to him. His reelection. He is already partially responsible for the virus’ spread in the U.S. after it was found that he delayed prepping for the pandemic because he believed that sick Americans would be bad optics for his campaign.
Now, he’s trying to wipe out the pathogen by bribing a German firm for a vaccine, but it’s not because he’s worried about dying Americans, so the whole thing is just really sinister.
According to Reuters:
Berlin is trying to stop Washington from persuading a German company seeking a coronavirus vaccine to move its research to the United States, prompting German politicians to insist no country should have a monopoly on any future vaccine.
Now, while many Republicans are praising Trump for being so bold for the sake of the American people, others know damn well that empathy is simply not a trait that Trump possesses. Not even for his own children.
The report continued:
German government sources told Reuters on Sunday that the U.S. administration was looking into how it could gain access to a potential vaccine being developed by a German firm, CureVac.
Earlier, the Welt am Sonntag German newspaper reported that U.S. President Donald Trump had offered funds to lure CureVac to the United States, and the German government was making counter-offers to tempt it to stay.
Responding to the report, the U.S. ambassador to Germany, Richard Grenell, wrote on Twitter: “The Welt story was wrong.”
The NY Times reported that Trump was attempting to bribe the German firm:
The Trump administration attempted to persuade a German firm developing a possible vaccine for coronavirus to move its research work to the United States, German officials said, raising fears in Berlin that President Trump was trying to assure that any inoculation would be available first, and perhaps exclusively, in the United States.
The offer arose from a March 2 meeting at the White House that included the chief executive of the German firm CureVac, Daniel Menichella. President Trump briefly attended the meeting and Vice President Mike Pence, who heads the White House coronavirus task force, was also there.
Less than two weeks after leaving the White House meeting with Trump, Menichella announced that he was leaving CurVac, but did not disclose the reasoning behind it. On Sunday, the company released the following statement:
“CureVac refrains from commenting on current media speculations and clearly rejects claims about the sale of the company or its technology.”
Germany’s interior minister, Horst Seehofer was asked by reporters whether the Trump Administration had tried to take over the company responsible for manufacturing a vaccine. He revealed that he had heard that “from several members of the government and it will be discussed tomorrow in the crisis team.”
Yet another official claimed that a “large sum” of money had been offered up by the U.S. to get their hands on a vaccine that would get people paying attention to politics again.
NY Times continues:
According to the German newspaper Die Welt am Sonntag, which first reported the story on Sunday, Mr. Trump offered CureVac roughly $1 billion in exchange for exclusive access to the vaccine. The newspaper quoted an unnamed German government source who said Mr. Trump wanted the resulting vaccine “only for the United States.”
But another German official, reached by The New York Times, said it was unclear whether the administration simply wanted the research work, and for any resulting production to be on American soil.